Does Sericin, as a Novel Pleurodesis Agent, Have Higher Effectiveness Compared to Talcum Powder, Doxycycline, and Silver Nitrate Pleurodesis?

• Published in: Archivos de bronconeumología (English ed.) 2019-07, Vol.55 (7), p.357-367
• Main Authors: Yazicioglu, Alkin, Uysal, Serkan, Sahinoglu, Tuba, Subasi, Mahmut, Demirag, Funda, Yekeler, Erdal
• Format: Article
• Language: English
• Subjects: Animals; Collagen - analysis; Cost-Benefit Analysis; Cost-effective; Coste-efectivo; Doxiciclina; Doxycycline; Doxycycline - economics; Doxycycline - therapeutic use; Doxycycline - toxicity; Drug Evaluation, Preclinical; Efectos secundarios; Emphysema - chemically induced; Epithelium - drug effects; Epithelium - pathology; Fibrosis; Foreign-Body Reaction - chemically induced; Lung - drug effects; Lung - pathology; Male; Myocardium - chemistry; Nitrato de plata; Parenchyma; Parénquima; Pleura; Pleura - drug effects; Pleura - pathology; Pleurodesis; Pleurodesis - adverse effects; Pleurodesis - economics; Pleurodesis - methods; polvos de talco; Pulmonary/Respiratory; Rats; Rats, Wistar; Sclerosing Solutions - economics; Sclerosing Solutions - therapeutic use; Sclerosing Solutions - toxicity; Sericin; Sericina; Sericins - economics; Sericins - therapeutic use; Sericins - toxicity; Side effect; Silver nitrate; Silver Nitrate - economics; Silver Nitrate - therapeutic use; Silver Nitrate - toxicity; Talc - economics; Talc - therapeutic use; Talc - toxicity; Talcum powder; Thoracotomy; Viscera - pathology
• ISSN: 0300-2896; 1579-2129
• DOI: 10.1016/j.arbres.2018.10.003

Graphical abstract